ID

15560

Beschreibung

Phase 1b/2 Study of Selinexor (KPT-330) in Combination w/ Backbone Treatments for Resistant/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT02343042

Link

https://clinicaltrials.gov/show/NCT02343042

Stichworte

Versionen (2)
  1. 03.06.16 03.06.16 -
  2. 03.06.16 03.06.16 - Julian Varghese
Hochgeladen am

3. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Multiple Myeloma NCT02343042

Englisch

Eligibility Multiple Myeloma NCT02343042

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis, measurable disease and evidence of disease progression of multiple myeloma, as described below.
Beschreibung

Diagnosis Histology | Measurable Disease | Multiple Myeloma | Disease Progression

Datentyp

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2]
C0242656
symptomatic multiple myeloma, based on imwg guidelines. patients must have measurable disease as defined by at least one of the following:
Beschreibung

Multiple Myeloma Symptomatic | Measurable Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C1513041
1. serum m-protein ≥ 5 g/l by serum electrophoresis (spep) or for immunoglobulin a (iga) myeloma, by quantitative iga; or
Beschreibung

M Protein | Serum protein electrophoresis | IgA myeloma | Immunoglobulin A measurement Quantitative

Datentyp

boolean

Alias
UMLS CUI [1]
C0700271
UMLS CUI [2]
C0201720
UMLS CUI [3]
C0563305
UMLS CUI [4,1]
C0202083
UMLS CUI [4,2]
C0392762
2. urinary m-protein excretion at least 200 mg/24 hours; or
Beschreibung

Excretion measurement M Protein In Urine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0201808
UMLS CUI [1,2]
C0700271
UMLS CUI [1,3]
C0042037
3. involved serum free light chains ≥ 100 mg/l, provided that free light chain ratio is abnormal
Beschreibung

Serum Free Immunoglobulin Light Chain Involvement | Serum Immunoglobulin Free Light Chain Ratio Abnormal

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2827352
UMLS CUI [1,2]
C1314939
UMLS CUI [2]
C2826181
4. if serum protein electrophoresis is felt to be unreliable for routine m-protein measurement, then quantitative immunoglobulin levels by nephelometry or turbidometry are acceptable.
Beschreibung

Serum protein electrophoresis unreliable | M Protein Measurement | Immunoglobulin level Quantitative | Nephelometry | Turbidimetry

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0201720
UMLS CUI [1,2]
C0749770
UMLS CUI [2,1]
C0700271
UMLS CUI [2,2]
C0242485
UMLS CUI [3,1]
C0428536
UMLS CUI [3,2]
C0392762
UMLS CUI [4]
C0027692
UMLS CUI [5]
C0041394
resolution of prior drug-related toxicities to ≤ grade 1.
Beschreibung

Resolution Toxic effect Due to Pharmaceutical Preparations

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514893
UMLS CUI [1,2]
C0600688
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0013227
relapsed and/or refractory multiple myeloma.
Beschreibung

Multiple Myeloma Relapsed | Refractory multiple myeloma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0205336
UMLS CUI [2]
C0278620
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
smoldering mm.
Beschreibung

Smoldering myeloma

Datentyp

boolean

Alias
UMLS CUI [1]
C1531608
multiple myeloma that does not express m-protein or free light chain(flc) (i.e., non-secretory mm is excluded), and quantitative immunoglobulin levels cannot be used instead.
Beschreibung

Multiple Myeloma | Gene Expression | M Protein | Free Immunoglobulin Light Chain | Non-secretory myeloma | Immunoglobulin level Quantitative

Datentyp

boolean

Alias
UMLS CUI [1]
C0700271
UMLS CUI [2,1]
C0026764
UMLS CUI [2,2]
C0806492
UMLS CUI [3]
C0456845
documented systemic amyloid light chain amyloidosis.
Beschreibung

Primary amyloidosis of light chain type Systemic | Amyloid

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0342606
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C0002716
active mm involving the central nervous system (cns).
Beschreibung

Multiple Myeloma Involvement with Central Nervous System

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C3714787
plasma cell leukemia.
Beschreibung

Leukemia, Plasma Cell

Datentyp

boolean

Alias
UMLS CUI [1]
C0023484
on the selinexor + dexamethasone + bortezomib (sdb) arm only: prior history of neuropathy grade > 2, or grade 2 neuropathy with pain at baseline (within 14 days prior to cycle 1 day 1).
Beschreibung

Protocol Treatment Arm selinexor Dexamethasone bortezomib | Neuropathy | Neuropathy, Painful

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522541
UMLS CUI [1,2]
C3852671
UMLS CUI [1,3]
C0011777
UMLS CUI [1,4]
C1176309
UMLS CUI [2]
C0442874
UMLS CUI [3]
C1850383
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Multiple Myeloma NCT02343042

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis Histology | Measurable Disease | Multiple Myeloma | Disease Progression
Item
histologically confirmed diagnosis, measurable disease and evidence of disease progression of multiple myeloma, as described below.
boolean
C0026764 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
Multiple Myeloma Symptomatic | Measurable Disease
Item
symptomatic multiple myeloma, based on imwg guidelines. patients must have measurable disease as defined by at least one of the following:
boolean
C0026764 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2])
M Protein | Serum protein electrophoresis | IgA myeloma | Immunoglobulin A measurement Quantitative
Item
1. serum m-protein ≥ 5 g/l by serum electrophoresis (spep) or for immunoglobulin a (iga) myeloma, by quantitative iga; or
boolean
C0700271 (UMLS CUI [1])
C0201720 (UMLS CUI [2])
C0563305 (UMLS CUI [3])
C0202083 (UMLS CUI [4,1])
C0392762 (UMLS CUI [4,2])
Excretion measurement M Protein In Urine
Item
2. urinary m-protein excretion at least 200 mg/24 hours; or
boolean
C0201808 (UMLS CUI [1,1])
C0700271 (UMLS CUI [1,2])
C0042037 (UMLS CUI [1,3])
Serum Free Immunoglobulin Light Chain Involvement | Serum Immunoglobulin Free Light Chain Ratio Abnormal
Item
3. involved serum free light chains ≥ 100 mg/l, provided that free light chain ratio is abnormal
boolean
C2827352 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C2826181 (UMLS CUI [2])
Serum protein electrophoresis unreliable | M Protein Measurement | Immunoglobulin level Quantitative | Nephelometry | Turbidimetry
Item
4. if serum protein electrophoresis is felt to be unreliable for routine m-protein measurement, then quantitative immunoglobulin levels by nephelometry or turbidometry are acceptable.
boolean
C0201720 (UMLS CUI [1,1])
C0749770 (UMLS CUI [1,2])
C0700271 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0428536 (UMLS CUI [3,1])
C0392762 (UMLS CUI [3,2])
C0027692 (UMLS CUI [4])
C0041394 (UMLS CUI [5])
Resolution Toxic effect Due to Pharmaceutical Preparations
Item
resolution of prior drug-related toxicities to ≤ grade 1.
boolean
C1514893 (UMLS CUI [1,1])
C0600688 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,4])
Multiple Myeloma Relapsed | Refractory multiple myeloma
Item
relapsed and/or refractory multiple myeloma.
boolean
C0026764 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
C0278620 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Smoldering myeloma
Item
smoldering mm.
boolean
C1531608 (UMLS CUI [1])
Multiple Myeloma | Gene Expression | M Protein | Free Immunoglobulin Light Chain | Non-secretory myeloma | Immunoglobulin level Quantitative
Item
multiple myeloma that does not express m-protein or free light chain(flc) (i.e., non-secretory mm is excluded), and quantitative immunoglobulin levels cannot be used instead.
boolean
C0700271 (UMLS CUI [1])
C0026764 (UMLS CUI [2,1])
C0806492 (UMLS CUI [2,2])
C0456845 (UMLS CUI [3])
Primary amyloidosis of light chain type Systemic | Amyloid
Item
documented systemic amyloid light chain amyloidosis.
boolean
C0342606 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0002716 (UMLS CUI [2])
Multiple Myeloma Involvement with Central Nervous System
Item
active mm involving the central nervous system (cns).
boolean
C0026764 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C3714787 (UMLS CUI [1,3])
Leukemia, Plasma Cell
Item
plasma cell leukemia.
boolean
C0023484 (UMLS CUI [1])
Protocol Treatment Arm selinexor Dexamethasone bortezomib | Neuropathy | Neuropathy, Painful
Item
on the selinexor + dexamethasone + bortezomib (sdb) arm only: prior history of neuropathy grade > 2, or grade 2 neuropathy with pain at baseline (within 14 days prior to cycle 1 day 1).
boolean
C1522541 (UMLS CUI [1,1])
C3852671 (UMLS CUI [1,2])
C0011777 (UMLS CUI [1,3])
C1176309 (UMLS CUI [1,4])
C0442874 (UMLS CUI [2])
C1850383 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video